Ensayo clínico

Stratagen Quantitative Prostate MRI Platform Pilot Study

NCT: NCT06985238 · ACTIVE_NOT_RECRUITING

ID NCTNCT06985238

EstadoACTIVE_NOT_RECRUITING

Fecha de inicio2025-09-24

Finalización2027-05-30

SponsorStratagen Bio, Inc. (INDUSTRY)

First posted2025-05-22

Last updated2026-10-09

Resumen breve

The goal of this clinical trial is to assess the safety and feasibility of the Stratagen Quantitative Prostate MRI Platform when used in addition to the standard scans conducted during the existing prostate MRI sessions. * What severe problems, if any, occur because of the use of the Stratagen Quantitative Prostate MRI Platform? * Can the data collected be used to measure quantitative MRI parameters? Participants will: \- Receive up to 15 minutes of additional MRI scan time during the existing prostate MRI imaging session.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.